Marinus Pharmaceuticals News

Express News | Marinus Pharmaceuticals Inc : RBC Cuts Target Price to $3 From $24

Moomoo 24/7just now

Express News | Marinus Pharmaceuticals Inc : RBC Cuts to Sector Perform From Outperform

Moomoo 24/71minutes ago

Express News | Marinus Pharmaceuticals Inc : Baird Cuts to Neutral Rating; Cuts Target Price to $2 From $20

Moomoo 24/752minutes ago

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks eased late Monday afternoon, with the NYSE Health Care Index decreasing 0.1% and the Health Care Select Sector SPDR Fund (XLV) down 0.2%. The iShares Biotechnology ETF (IBB) fell 1.

MT Newswires15:59 ET

Marinus Pharmaceuticals Cut to Sector Perform From Outperform by RBC Capital

Marinus Pharmaceuticals Cut to Sector Perform From Outperform by RBC Capital

Dow Jones15:02 ET

Express News | RBC Capital Downgrades Marinus Pharma to Sector Perform, Lowers Price Target to $3

Moomoo 24/714:52 ET

Marinus Pharma Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/15/2024 123.96% RBC Capital $24 → $3 Downgrades Outperform → Sector Perform 04/10/2024 1990.33% Cantor

Benzinga14:51 ET

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d

Benzinga14:11 ET

Trending Stocks Today: Kaival Brands Innovations Shoots up 130%

April 15th - US stocks trending in regular trading hours.Gainers: $Kaival Brands Innovations(KAVL.US)$ shoots up 130% to $6.14 with a turnover of $288.45 million. $Longeveron(LGVN.US)$ surges 51.47% t

moomoo News14:10 ET

Maintaining Buy Rating on Marinus Pharmaceuticals: Confidence in Research and Strategic Financial Health

TipRanks13:25 ET

Marinus Pharmaceuticals: A Strong Buy Despite RAISE Trial Setback, With Promising Growth Potential in DEE Market

TipRanks13:05 ET

BSGM, ENLV and WISA Among Mid-day Movers

Seeking Alpha12:47 ET

Express News | Marinus Pharmaceuticals Inc : Jefferies Cuts Target Price to $6 From $22

Moomoo 24/7Apr 15 11:41 ET

Marinus Plummets 78% as Phase 3 Interim Analysis of Ganaxolone Disappoints

Seeking AlphaApr 15 11:00 ET

Marinus Pharmaceuticals, Cartesian Therapeutics, Adial Pharmaceuticals Among Healthcare Movers

Seeking AlphaApr 15 10:00 ET

Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.89% to 38,321.05 while the NASDAQ rose 0.70% to 16,288.03. The S&P 500 also

BenzingaApr 15 10:00 ET

Express News | Marinus Pharmaceuticals Shares Are Trading Lower After the Company Provided an Update on the Phase 3 RAISE Trial and Reported Preliminary Q1 Financial Results

Moomoo 24/7Apr 15 08:46 ET

NXPL, MGRM and OCX Among Pre-market Losers

Seeking AlphaApr 15 08:21 ET

Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday. Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) fell sharply in today's pre-market trading a

BenzingaApr 15 08:19 ET

12 Health Care Stocks Moving In Monday's Pre-Market Session

GainersSoligenix (NASDAQ:SNGX) stock increased by 95.1% to $0.75 during Monday's pre-market session. The company's market cap stands at $7.9 million. Longeveron (NASDAQ:LGVN) shares increased by 51.47

BenzingaApr 15 08:07 ET